Immune to Cancer: The CRI Blog
-
Dr. Ana Aparicio Answers Questions About Prostate Cancer and Immunotherapy After the 2021 CRI Virtual Immunotherapy Patient Summit
Dr. Ana Aparicio, of The University of Texas MD Anderson Cancer Center, answers questions about prostate cancer…
-
Prostate Cancer Awareness Month: 2021 Immunotherapy Research Updates
This September for Prostate Cancer Awareness Month, we examine promising new treatments, new research, and how we’re…
-
Dr. Sumit Subudhi Answers Questions on Prostate Cancer and Immunotherapy from the CRI Virtual Immunotherapy Patient Summit
Sumit K. Subudhi, MD, PhD, answers questions on immunotherapy for prostate cancer from the 2020 CRI Virtual Immunotherapy…
-
Prostate Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Prostate Cancer Awareness Month, we look at new treatment combinations, new research, and how…
-
Advances in Immunotherapy for Prostate Cancer with Dr. Sumit Subudhi
For Prostate Cancer Awareness Month, CRI spoke with Dr. Sumit Subudhi about advances in immunotherapy for prostate…
-
PORTER Immunotherapy Clinical Trial for Prostate Cancer Unveiled at SITC2019
Details of a promising new CRI co-funded clinical trial for metastatic prostate cancer unveiled at the 2019…
-
Prostate Cancer Awareness Month: 2019 Immunotherapy Research Update
For Prostate Cancer Awareness Month, we round up the latest news and research from the people changing…
-
How Immunotherapy Is Making an Impact in Prostate Cancer
We spoke with Sumit K. Subudhi, MD, PhD, about the current treatment landscape for patients with prostate…